Novel vaccine targeting alpha-lactalbumin, a protein expressed in 70% of triple-negative breast cancers but otherwise found only in lactating breast tissue, shows early immune response in Phase 1 trial.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
FTC finalizes rule requiring subscription-based businesses to provide cancellation processes as simple as enrollment methods, effective 180 days after Federal Register publication.
Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.